Alex Goldberg

NASDAQ Active Stock Watch List: SINA Corporation (NASDAQ:SINA) and BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Added to Equity Profile Report's NASDAQ Active Stock Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/24/2014 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding SINA Corporation (NASDAQ:SINA) and BioMarin Pharmaceutical Inc. (NASDAQ:BMRN).

SINA Corporation (NASDAQ:SINA) through its subsidiaries, operates as an online media company in the Peoples Republic of China closed down in its previous session (-1.26%) on 2,556,614 shares traded after SINA Corporation Announced to Report Fourth Quarter 2013 Financial Results On February 24, 2014. SINA Corporation (NASDAQ:SINA) is currently down (-21.81%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about SINA Corporation (NASDAQ:SINA)

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) a company that develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally closed up in its previous session (+1.73%) on 2,192,598 shares traded after BioMarin Received Positive Opinion From the CHMP in the European Union for VIMIZIM for Morquio A Syndrome. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is currently up (+53.87%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com